Tag:

Hawaii Biotech

Latest Headlines

Latest Headlines

U.S. Army, Hawaii Biotech join for dengue vaccine effort

December 8, 2015 | By
Seeking a dengue fever vaccine that can offer broad protection in a short time, the U.S. Army has awarded Hawaii Biotech a Phase I contract to support the company's work against the "potentially mission-aborting" disease, according to a press release.

Hawaii Biotech rises from Chapter 11

FiercePharma | June 21, 2011
One year after selling its dengue vaccine research, Hawaii Biotech has come out of Chapter 11 bankruptcy. The company filed for reorganization protection back in December 2009. "This is a significant

Merck buys vax unit from bankrupt Hawaii Biotech

FierceBiotech | July 21, 2010
Merck (NYSE: MRK) has agreed to purchase bankrupt Hawaii Biotech 's dengue fever vaccine unit for an undisclosed sum. It's a critical move for Hawaii, which filed for Chapter 11 bankruptcy protection

Hawaii Biotech power struggle heads into bankruptcy court

FierceBiotech | December 14, 2009
With its biggest shareholder expected to make a power grab at an annual meeting on Wednesday, Hawaii Biotech has filed for Chapter 11 bankruptcy protection. A report in Pacific Business News notes

Hawaii Biotech: Phase I West Nile vax trial a success

FierceBiotech | February 25, 2009
Hawaii Biotech announced the successful completion of a Phase I clinical trial for its West Nile Virus vaccine. The recombinant sub-unit vaccine was found to be safe among healthy volunteers who had

Hawaii Biotech: Phase I West Nile vax trial a success

February 25, 2009 | By
Hawaii Biotech announced the successful completion of a Phase I clinical trial for its West Nile Virus vaccine. The recombinant sub-unit vaccine was found to be safe among healthy volunteers who had

Brazilian Dengue outbreak highlights vaccine need

April 10, 2008
An outbreak of dengue fever in and around Rio de Janeiro has afflicted more than 75,000 people since the beginning of the year, with 12 people dying in just the past week. No vaccine is available

Hawaii Biotech moves West Nile vaccine into clinic

January 10, 2008
Hawaii Biotech has passed a key milestone in its development, winning approval to begin a small human trial of its experimental vaccine to combat West Nile disease. Hawaii Biotech says that the FDA
Related Tags

Hawaii Biotech Press Releases

  • Hawaii Biotech, Inc. Licenses Vaccine Technology from Merck & Co., Inc.
  • Hawaii Biotech Initiates Phase 1 Clinical Trial for Dengue Vaccine
  • Hawaii Biotech Completes Dosing of Phase 1 Trial for West Nile Virus Vaccine
  • Hawaii Biotech Receives Allowance To Perform West Nile Vaccine Clinical Trials
Press Releases
  • Merck Statement on hep C verdict
  • Quanterix Raises $46 Million in Series D Financing
  • Opening Arguments Today in Largest US Pharma Theft Civil Suit
  • Award of Funding for Next Stage of US Department of Defense Programme to Develop Genedrive® Biohazard Identification Tests
  • Men in England to finally have routine access to UK-discovered prostate cancer medicine Zytiga (abiraterone acetate) before chemotherapy
  • More Press Releases
Sponsored Links